1,2-dimethylhydrazine multiple interactions ISO RGD:10508 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EFNB1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:10508 6480464 Ethinyl Estradiol affects the expression of EFNB1 mRNA CTD PMID:17555576 17beta-estradiol affects expression ISO RGD:10508 6480464 Estradiol affects the expression of EFNB1 mRNA CTD PMID:15598610 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of EFNB1 mRNA CTD PMID:21602191 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EFNB1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EFNB1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10508 6480464 Tetrachlorodibenzodioxin affects the expression of EFNB1 mRNA CTD PMID:21570461 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737327 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EFNB1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:10508 6480464 Methylcholanthrene results in increased expression of EFNB1 mRNA CTD PMID:20713471 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of EFNB1 mRNA CTD PMID:24780913 acrylamide decreases expression ISO RGD:737327 6480464 Acrylamide results in decreased expression of EFNB1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:737327 6480464 Aflatoxin B1 results in increased expression of EFNB1 mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:737327 6480464 Aflatoxin B1 results in decreased methylation of EFNB1 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:10508 6480464 Tretinoin results in increased expression of EFNB1 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:737327 6480464 Tretinoin results in decreased expression of EFNB1 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EFNB1 mRNA CTD PMID:16483693 aristolochic acid increases expression ISO RGD:737327 6480464 aristolochic acid I results in increased expression of EFNB1 mRNA CTD PMID:33212167 arsane increases expression ISO RGD:10508 6480464 Arsenic results in increased expression of EFNB1 mRNA CTD PMID:24019935 arsenic atom increases expression ISO RGD:10508 6480464 Arsenic results in increased expression of EFNB1 mRNA CTD PMID:24019935 arsenite(3-) increases expression ISO RGD:10508 6480464 arsenite results in increased expression of EFNB1 mRNA CTD PMID:33053406 atrazine increases expression ISO RGD:737327 6480464 Atrazine results in increased expression of EFNB1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:737327 6480464 Benzo(a)pyrene results in increased expression of EFNB1 mRNA CTD PMID:22316170 , PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:737327 6480464 Benzo(a)pyrene results in decreased methylation of EFNB1 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:737327 6480464 Benzo(a)pyrene affects the methylation of EFNB1 5' UTR, Benzo(a)pyrene affects the methylation of EFNB1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:10508 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA CTD PMID:27858113 benzo[b]fluoranthene decreases expression ISO RGD:10508 6480464 benzo(b)fluoranthene results in decreased expression of EFNB1 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:10508 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA CTD PMID:27858113 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EFNB1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:737327 6480464 bisphenol A results in decreased methylation of EFNB1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:10508 6480464 bisphenol A results in increased expression of EFNB1 mRNA CTD PMID:34585602 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EFNB1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A multiple interactions ISO RGD:737327 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFNB1 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:737327 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EFNB1 mRNA CTD PMID:28628672 cadmium atom decreases expression ISO RGD:10508 6480464 Cadmium results in decreased expression of EFNB1 mRNA CTD PMID:24067728 cadmium dichloride decreases expression ISO RGD:737327 6480464 Cadmium Chloride results in decreased expression of EFNB1 mRNA CTD PMID:26472689 carbon nanotube decreases expression ISO RGD:737327 6480464 Nanotubes, Carbon results in decreased expression of EFNB1 mRNA CTD PMID:25511174 carbon nanotube decreases expression ISO RGD:10508 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:737327 6480464 CGP 52608 promotes the reaction [RORA protein binds to EFNB1 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO RGD:10508 6480464 Chlorpyrifos results in decreased expression of EFNB1 mRNA CTD PMID:20350560 chrysene decreases expression ISO RGD:10508 6480464 chrysene results in decreased expression of EFNB1 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:10508 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO RGD:737327 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of EFNB1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:737327 6480464 Cisplatin results in increased expression of EFNB1 mRNA CTD PMID:27392435 , PMID:27594783 cocaine increases expression EXP 6480464 Cocaine results in increased expression of EFNB1 mRNA CTD PMID:15691709 , PMID:17898221 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of EFNB1 mRNA CTD PMID:26577399 dexamethasone multiple interactions ISO RGD:737327 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EFNB1 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:10508 6480464 Dibutyl Phthalate results in decreased expression of EFNB1 mRNA CTD PMID:21266533 doxorubicin increases expression ISO RGD:737327 6480464 Doxorubicin results in increased expression of EFNB1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of EFNB1 mRNA CTD PMID:29391264 fenthion decreases expression ISO RGD:10508 6480464 Fenthion results in decreased expression of EFNB1 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:10508 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EFNB1 mRNA CTD PMID:22206623 furan increases methylation EXP 6480464 furan results in increased methylation of EFNB1 gene CTD PMID:22079235 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of EFNB1 mRNA CTD PMID:22061828 , PMID:33387578 indometacin multiple interactions ISO RGD:737327 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EFNB1 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:737327 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EFNB1 mRNA CTD PMID:29432896 leflunomide decreases expression ISO RGD:737327 6480464 leflunomide results in decreased expression of EFNB1 mRNA CTD PMID:28988120 maneb multiple interactions ISO RGD:10508 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of EFNB1 mRNA CTD PMID:23017109 mercury atom increases expression ISO RGD:737327 6480464 Mercury results in increased expression of EFNB1 mRNA CTD PMID:16823088 mercury(0) increases expression ISO RGD:737327 6480464 Mercury results in increased expression of EFNB1 mRNA CTD PMID:16823088 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of EFNB1 mRNA CTD PMID:19564919 methidathion decreases expression ISO RGD:10508 6480464 methidathion results in decreased expression of EFNB1 mRNA CTD PMID:34813904 methotrexate affects expression ISO RGD:10508 6480464 Methotrexate affects the expression of EFNB1 mRNA CTD PMID:18502557 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of EFNB1 mRNA, nitrofen results in decreased expression of EFNB1 protein CTD PMID:30469162 paraquat multiple interactions ISO RGD:10508 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of EFNB1 mRNA CTD PMID:23017109 pentachlorophenol increases expression ISO RGD:10508 6480464 Pentachlorophenol results in increased expression of EFNB1 mRNA CTD PMID:23892564 phenobarbital affects expression ISO RGD:737327 6480464 Phenobarbital affects the expression of EFNB1 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:10508 6480464 Phenobarbital affects the expression of EFNB1 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:10508 6480464 pirinixic acid results in increased expression of EFNB1 mRNA CTD PMID:18301758 potassium dichromate increases expression ISO RGD:737327 6480464 Potassium Dichromate results in increased expression of EFNB1 protein CTD PMID:23718831 propiconazole decreases expression ISO RGD:10508 6480464 propiconazole results in decreased expression of EFNB1 mRNA CTD PMID:21278054 SCH 23390 increases expression EXP 6480464 SCH 23390 results in increased expression of EFNB1 mRNA CTD PMID:19564919 sodium arsenite decreases expression ISO RGD:10508 6480464 sodium arsenite results in decreased expression of EFNB1 mRNA CTD PMID:16014739 sodium arsenite increases expression ISO RGD:737327 6480464 sodium arsenite results in increased expression of EFNB1 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of EFNB1 mRNA CTD PMID:19281266 tetraphene multiple interactions ISO RGD:10508 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EFNB1 mRNA CTD PMID:34492290 trichloroethene increases expression ISO RGD:10508 6480464 Trichloroethylene results in increased expression of EFNB1 mRNA CTD PMID:15363585 urethane increases expression ISO RGD:737327 6480464 Urethane results in increased expression of EFNB1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:10508 6480464 Valproic Acid affects the expression of EFNB1 mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:737327 6480464 Valproic Acid results in increased methylation of EFNB1 gene CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of EFNB1 mRNA CTD PMID:18042343